Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride
Status:
COMPLETED
Trial end date:
2024-01-23
Target enrollment:
Participant gender:
Summary
Sixty-eight healthy subjects were divided into three sequences: A, B and C. The effects of CYP2C19 inhibitor fluconazole and inducer rifampicin on ET-26-HCl injection were evaluated, and the effects of ET-26-HCl injection on pharmacokinetics of omeprazole and midazolam were evaluated.